KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Non-Current Debt (2016 - 2025)

Idexx Laboratories has reported Non-Current Debt over the past 17 years, most recently at $374.8 million for Q4 2025.

  • Quarterly results put Non-Current Debt at $374.8 million for Q4 2025, down 16.66% from a year ago — trailing twelve months through Dec 2025 was $374.8 million (down 16.66% YoY), and the annual figure for FY2025 was $374.8 million, down 16.66%.
  • Non-Current Debt for Q4 2025 was $374.8 million at Idexx Laboratories, roughly flat from $374.8 million in the prior quarter.
  • Over the last five years, Non-Current Debt for IDXX hit a ceiling of $780.1 million in Q2 2021 and a floor of $374.8 million in Q3 2025.
  • Median Non-Current Debt over the past 5 years was $658.6 million (2022), compared with a mean of $625.6 million.
  • Biggest five-year swings in Non-Current Debt: rose 11.67% in 2021 and later decreased 28.57% in 2025.
  • Idexx Laboratories' Non-Current Debt stood at $775.2 million in 2021, then dropped by 10.43% to $694.4 million in 2022, then fell by 10.3% to $622.9 million in 2023, then dropped by 27.79% to $449.8 million in 2024, then decreased by 16.66% to $374.8 million in 2025.
  • The last three reported values for Non-Current Debt were $374.8 million (Q4 2025), $374.8 million (Q3 2025), and $449.8 million (Q2 2025) per Business Quant data.